Conference Reports for NATAP

13th IAS Conference on HIV Science IAS 2026 July 26-31 Rio, Brazil Back

Open-Label Phase 1 Study to Evaluate Relative Bioavailability and Food Effect on the Pharmacokinetics of the Fixed-Dose Combination of Doravirine/Islatravir (100 mg/0.25 mg) in Adults Without HIV       IAS 2026 Rio, Brazil